Redpill Breath
Pre-commercial- Indications
- respiratory rehabilitation
Company intelligence / Profile preview
LifeSemantics has successfully completed a clinical study on its skin cancer image detection and diagnostic assistance software—the first such performance demonstration of medical AI for skin cancer in Korea. Other products targeting hypertension complications and home blood pressure monitoring are nearing completion of trials with expected commercialization soon. The company’s platforms integrate lifelog/genomic/clinical data to enable predictive analytics across multiple disease areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeSemantics.